The K-Map Study, Global Prevalence of KC
University Hospital, Geneva · with ELZA Institute · NCT03115710
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 6–23 · All sexes
- Healthy volunteers
- Accepted
- Study type
- Observational
- Target enrollment
- 20000
- US sites recruiting
- 1
- Study start
- December 28, 2015
- Record last updated
- August 11, 2025
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
Keratoconus is a ocular disease classified under ectatic diseases which often results in bilateral and asymmetrical corneal distortion. It usually affects patients at young age and can cause severe visual loss.
The overall goal of this study is to assess the prevalence of keratoconus (KC) in children and adolescents in various regions of the world based on modern tomographic imaging methods, and to verify whether the occurrence rates reported from literature should be corrected. Our hypothesis is that the prevalence of the disease is much higher than that traditionally reported.
At each site, corneal tomography examinations (Pentacam) will be performed bilaterally in children and adolescents, who are not ill or with any ophthalmological symptom. The population to be studied will be composed of children and adolescents on medical visits for non-ophthalmologic reasons, aged between 6 and 20 years. Multiple cities, from different continents (North America, South America, Asia and Europe) will participate.
Being studied: Rotating Scheimpflug camera (Pentacam HR)
Conditions: Keratoconus
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Male or female, 6-23 years of age.
- Subjects seen for a non-ophthalmic appointment
- Provide signed and dated patient consent form (signed by parents / legal guardians).
- Willing to comply with all study procedures and be available for the duration of the study
Exclusion Criteria
- Patients with a preexisting ocular disease / condition
- Pregnancy or breastfeeding
Recruiting US locations
USC Roski Eye Institute
Los Angeles, CA 90033
Site contact: J. Bradley Randleman, MD
Study contacts (from the official record)
- Farhad Hafezi, MDPhD · +41 44 741 81 81 · fhafezi@elza-institute.com
Similar studies in California
All healthy volunteers studies in California →- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
A Study to Investigate the Relative Bioavailability and Safety of Different Oral Formulations of Elecoglipron in Healthy Participants
AstraZeneca
- Location
- Glendale, CA + 1 other US site
- Eligibility basics
- Ages 18–55
- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
A Phase I Study to Investigate the Pharmacokinetics and Safety of Capivasertib in Participants With Moderate Hepatic Impairment
AstraZeneca
- Location
- Rialto, CA + 1 other US site
- Eligibility basics
- Ages 18–80
- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
A Study to Learn How the Body Processes the Study Medicine PF-07328948 in People With Reduced Kidney Function
Pfizer
- Location
- Lake Forest, CA + 3 other US sites
- Eligibility basics
- Ages 18–80
- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
Phase 1 Study of SBS-147 in Healthy Adults
Sparian Biosciences, Inc
- Location
- Cypress, CA
- Eligibility basics
- Ages 18–55